Time New York: Mon 23 Oct 01:54 am  |  Save 15% on H&R Block Online

  

Stock market analysts report on breaking news, sectors, stocks, and the overall markets.

caticonslite_bm_alt

Celgene Down on Discontinued Crohn’s Disease Drug Study

caticonslite_bm_alt

Gilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval

caticonslite_bm_alt

Can Higher Oil Drive Whiting Petroleum’s (WLL) Q3 Earnings?

caticonslite_bm_alt

Akamai (AKAM) Q3 Earnings to Be Driven by Higher Traffic

caticonslite_bm_alt

Roche (RHHBY) Reports Sales Numbers for First 9 Months

caticonslite_bm_alt

Facebook to Build Subscription Platform via Instant Articles

caticonslite_bm_alt

Cancer Treatment Update: Second Gene Therapy Receives Approval

caticonslite_bm_alt

Factors Likely to Decide Kimberly’s (KMB) Fate in Q3 Earnings

caticonslite_bm_alt

Abbvie Inks Immuno-Oncology Deal with Harpoon Therapeutics

caticonslite_bm_alt

BioLineRx/Roche Scan BL-8040-Tecentriq for Gastric Cancer